A complete application in a minute
Tailored resume and cover letter, ready to send.
Johnson & Johnson in Switzerland seeks a Business Unit Director – Joint Reconstruction to own strategy, growth, profitability, and commercial execution for the Swiss business. You will lead national commercial and marketing teams and partner with finance and operations.
Define the national strategy with digital solutions, drive asset efficiency, and build a high-performing leadership team while coordinating with regional and global peers. German and English fluency required.
At Johnson & Johnson,we believe health is everything.
Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com . As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.
We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
The Business Unit Director - Joint Reconstruction holds end-to-end accountability for strategy, growth, profitability, asset efficiency, and commercial execution of the Joint Reconstruction business in Switzerland. The role leads the Joint Reconstruction commercial and marketing teams, and has dotted responsibility for the enabling technologies, including robotics, navigation, and capital equipment. Technology is a fundamental pillar of the overall strategy, supporting a differentiated value proposition based on the combination of implant, technique, and technology. This executive role requires strong strategic leadership combined with hands-on operational execution across a complex, capital-intensive portfolio.
On October 14, 2025, Johnson & Johnson announced plans to separate our Orthopedics business to establish a standalone orthopedics company, operating as DePuy Synthes. The planned separation is anticipated to be completed within 18 to 24 months, subject to legal requirements including consultation with works councils and other employee representative bodies, as may be required, regulatory approvals and other customary conditions and approvals. It is anticipated following conclusion of the transaction, you would be an employee of DePuy Synthes, and your employment would be governed by Orthopedics employment processes, programs, policies, and benefit plans. Details of any planned changes would be provided to you by Orthopedics at an appropriate time and subject to any necessary consultation processes.
Account Management, AI solution evaluation, Client Management, Commercial Awareness, Commercial Laws, Commercial Management, Corporate Management, Critical Thinking, Customer Effort Score, Customer Retentions, Developing Others, Inclusive Leadership, Leadership, Market Savvy, Negotiation, Operational Excellence, Pricing Strategies, Professional Ethics, Profitability Analysis, Stakeholder Engagement